Impact of Exercise Training on Ischemia With Non-Obstructive Coronary Arteries (INOCA): The ExINOCA Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorBispebjerg Hospital

About this trial

The purpose of the study is to identify causes of chest pain in patients experiencing chest pain with no signs of narrowing of the coronary arteries of the heart, and to investigate whether physical exercise can improve coronary microvascular function.

Hypotheses:

The first hypothesis is that in INOCA, with reduced function of microvasculature of the heart, this reduced function also occurs in other organs of the body.

The second hypothesis is that regular physical activity (aerobic exercise training) can improve coronary microvascular function, reduce symptoms, and that there is a parallel improvement in vascular function in other organs of the body.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Coronary microvascular dysfunction, defined as myocardial bloodflow reserve (MBFR) < 2.5 or hyperemic myocar-dial blood flow (hMBF)<2.3 ml/g/min using [15O]H2O-PET

No obstructive coronary artery disease

Disqualifiers

Females of childbearing potential (defined as a premeno-pausal female capable of becoming pregnant). The female patient must either be postmenopausal, defined as amen-orrhea for at least 1 year, or surgically sterile

Heart failure, defined as left ventricular ejection fraction of less than 40%

Uncontrolled hypertension defined as blood pressure above target 140/90 for all

Co-morbidity resulting in <1 year expected survival

Trial design

Design model

Parallel

Treatments tested in this trial

  • Exercise training

    Other intervention

    The training sessions are consist of cycling and as follows: a 10 min warm-up at a light intensity, 20-35 min of cycling exercise in intervals at varying intensities from light (\~60% of max heart rate) to more intensive (80-90% of max heart rate) and ending with 5 min of warm-down at a light intensity. The training intensity will be progressive during the course of the intervention period. The cycling training sessions are supervised . Home training is allowed up to once a week if participants are able to adhere to the prescribed intensity levels. Training sessions are closely monitored to ensure effectiveness and safety. This includes heart rate monitoring, perceived exertion assessment.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: ExerciseActive comparator 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in Myocardial Blood Flow Reserve (MBFR)

Change in MBFR assessed by \[15O\]H2O-PET-scan

Time frame
From baseline and after 3 months

Secondary outcomes

1

Change in symptom burden assessed by Seattle Angina Questionnaire

Seattle angina questionnaire/selfreported (scale range 0-100, 0=poor and 100=excellent health status)

Time frame
From baseline and after 3 months
2

Change in exercise capacity

Oxygen uptake during exhaustive exercise

Time frame
From baseline and after 3 months
3

Change in global rest perfusion in patients with angina symptoms and CMD

Change in Myocardial Blood Flow assessed by \[15O\]H2O-PET-scan

Time frame
From baseline and after 3 months
4

Change in global stress perfusion in patients with angina symptoms and CMD

Change in hyperemic Myocardial Blood Flow assessed by \[15O\]H2O-PET-scan

Time frame
From baseline and after 3 months

Other outcomes

1

Vascular Function Adaptations

Changes in Arterial compliance (C = ΔV/ ΔP) calculated from intraarterial pressure ΔP and arterial diameter (ΔD) measured by ultrasound Doppler

Time frame
From baseline and after 3 months
2

Changes in skin microvascular function

Hand microcirculatory blood flow assessed by Laser Speckle Contrast Imaging

Time frame
From baseline and after 3 months
3

Change in plasma levels of markers related to vascular function

Plasma levels of markers related to vascular function assessed by Mesoscale/ELISA

Time frame
From baseline and after 3 months
4

Changes in Arterial Blood Pressure

Assessed by automated blood pressure at rest

Time frame
From baseline and after 3 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Bispebjerg Hospital

Lead sponsor

University of Copenhagen

Collaborator